Literature DB >> 21605653

The effects of Buyang Huanwu Decoction on hemorheological disorders and energy metabolism in rats with coronary heart disease.

Wei-Rong Wang1, Rong Lin, Hui Zhang, Qin-Qin Lin, Li-Na Yang, Kai-Fan Zhang, Feng Ren.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Buyang Huanwu Decoction (BYHWD), a traditional Chinese medicine (TCM) formula, has been recognized as a clinical treatment for coronary heart disease (CHD) with qi deficiency and blood stasis syndrome. The effects of BYHWD on hemorheological disorders and energy metabolism in CHD with qi deficiency and blood stasis syndrome are still unclear. AIM OF THE STUDY: To investigate whether the ameliorative effects of BYHWD on CHD rats with qi deficiency and blood stasis syndrome are associated with the regulation of hemorheological disorders and energy metabolism.
MATERIALS AND METHODS: The rats were lavaged with 25.68, 12.84 and 6.42 g/kg BYHWD (g weight of mixed crude drugs/kg body weight), respectively, once a day for 21 days. The body weight, exhaustive swimming time and tongue characters were observed and recorded. The whole blood viscosity and plasma viscosity were determined by hematology analyzer. The level of fibrinogen (Fbg) in plasma was determined by using Fbg assay kit. The platelet aggregation induced by adenosine diphosphatase was measured by semi-automatic whole blood platelet analyzer. The level of blood glucose (BG) was determined by LifeScan. The activity of Na(+)-K(+)-ATPase in heart tissues was detected by spectrophotometer.
RESULTS: BYHWD improved the exterior signs of qi deficiency and blood stasis syndrome in rats with CHD, including the body weight, exhaustive swimming time and tongue quality. The whole blood viscosity in rats treated with 25.68 g/kg BYHWD decreased at the shear rate of 10s(-1) (P<0.05) and the plasma viscosity decreased in rats treated with 25.68 and 12.84 g/kg BYHWD (P<0.05). The plasma Fbg level and the platelet aggregation decreased in rats treated with 25.68 g/kg BYHWD (P<0.01). The results also revealed that the BG level decreased and the Na(+)-K(+)-ATPase activity in heart tissues increased in rats treated with 25.68 and 12.84 g/kg BYHWD (P<0.01).
CONCLUSION: The results suggest that the ameliorative effects of BYHWD on CHD rats with qi deficiency and blood stasis syndrome are mediated by the improvement of hemorheological disorders and energy metabolism.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21605653     DOI: 10.1016/j.jep.2011.05.008

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  22 in total

1.  Identification of metabolites of Buyang Huanwu decoction in rat urine using liquid chromatography-quadrupole time-of-flight mass spectrometry.

Authors:  Xiao-Dong Wen; E-Hu Liu; Jie Yang; Chang-Yin Li; Wen Gao; Lian-Wen Qi; Chong-Zhi Wang; Chun-Su Yuan; Ping Li
Journal:  J Pharm Biomed Anal       Date:  2012-04-25       Impact factor: 3.935

Review 2.  Research Progress of Traditional Chinese Medicine in Treatment of Myocardial fibrosis.

Authors:  Chunzhen Ren; Kai Liu; Xinke Zhao; Huan Guo; Yali Luo; Juan Chang; Xiang Gao; Xinfang Lv; Xiaodong Zhi; Xue Wu; Hugang Jiang; Qilin Chen; Yingdong Li
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

3.  Buyanghuanwu Tang therapy for neonatal rats with hypoxic ischemic encephalopathy.

Authors:  Xiyao Liu; Yue Min; Weiwang Gu; Yujue Wang; Yuguang Tian
Journal:  Int J Clin Exp Med       Date:  2015-10-15

4.  Neuroprotective effect of buyang huanwu decoction on rat ischemic/reperfusion brain damage by promoting migration of neural precursor cells.

Authors:  Xiangying Kong; Xiaohui Su; Jia Zhu; Jianzhu Wang; Hongye Wan; Micun Zhong; Li Li; Na Lin
Journal:  Rejuvenation Res       Date:  2014-06-11       Impact factor: 4.663

5.  YiqiHuoxue Decoction and Its Ethanol Precipitation Show Anti-Platelet and Antithrombotic Effects by Suppressing Thromboxane B2 Formation.

Authors:  Hong Wu; Zhen Lei; Shuibo Gao; Liping Dai; Yongjun Han; Haixia Gao; Xinzhou Wang; Zhentao Wang; Lihua Han
Journal:  Acta Cardiol Sin       Date:  2019-09       Impact factor: 2.672

6.  The active principle region of Buyang Huanwu decoction induced differentiation of bone marrow-derived mesenchymal stem cells into neural-like cells: Superior effects over original formula of Buyang Huanwu decoction.

Authors:  Jinghui Zheng; Yi Wan; Jianhuai Chi; Dekai Shen; Tingting Wu; Weimin Li; Pengcheng Du
Journal:  Neural Regen Res       Date:  2012-02-05       Impact factor: 5.135

Review 7.  Buyang huanwu decoction for healthcare: evidence-based theoretical interpretations of treating different diseases with the same method and target of vascularity.

Authors:  Ji-Huang Li; Ai-Ju Liu; Hui-Qin Li; Yan Wang; Hong-Cai Shang; Guo-Qing Zheng
Journal:  Evid Based Complement Alternat Med       Date:  2014-07-14       Impact factor: 2.629

8.  Mitogen activated protein kinase signaling pathways participate in the active principle region of Buyang Huanwu decoction-induced differentiation of bone marrow mesenchymal stem cells.

Authors:  Jinghui Zheng; Jian Liang; Xin Deng; Xiaofeng Chen; Fasheng Wu; Xiaofang Zhao; Yuan Luo; Lei Fu; Zuling Jiang
Journal:  Neural Regen Res       Date:  2012-06-25       Impact factor: 5.135

9.  HPLC-MS/MS analysis of a traditional Chinese medical formulation of Bu-Yang-Huan-Wu-Tang and its pharmacokinetics after oral administration to rats.

Authors:  Lee-Hsin Shaw; Lie-Chwen Lin; Tung-Hu Tsai
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

10.  Clinical data mining of phenotypic network in angina pectoris of coronary heart disease.

Authors:  Jianxin Chen; Peng Lu; Xiaohan Zuo; Qi Shi; Huihui Zhao; Liangtao Luo; Jianqiang Yi; Chenglong Zheng; Yi Yang; Wei Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-06-12       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.